Wnt therapy for bone loss: Golden goose or Trojan horse?

Journal of Clinical Investigation

Volumn 119, Issue 4, 2009, Pages 758-760

  Enders, Greg H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; WNT1 PROTEIN; ZOLEDRONIC ACID; REPRESSOR PROTEIN; SCLEROPROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; WIF1 PROTEIN, HUMAN; WIF1 PROTEIN, MOUSE; WNT PROTEIN;

BONE GROWTH; CARCINOGENESIS; DNA METHYLATION; DRUG ANTAGONISM; EPIGENETICS; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SILENCING; HUMAN; KNOCKOUT MOUSE; NOTE; OSTEOLYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR MODEL; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; GENETICS; MOUSE; OSTEOPOROSIS; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; EXTRACELLULAR MATRIX PROTEINS; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MODELS, BIOLOGICAL; OSTEOPOROSIS; OSTEOSARCOMA; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 65249158429     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38973     Document Type: Note

References (24)

1. Dovio, A., Micossi, I., Bianco, E., and Angeli, A. 2008. Determinants of glucocorticoid action in the bone microenvironment. J. Endocrinol. Invest. 31:7-15.
2. Wang, F.S., Ko, J.Y., Yeh, D.W., Ke, H.C., and Wu, H.L. 2008. Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss. Endocrinology. 149:1793-1801.
3. Haleem, S., Lutchman, L., Mayahi, R., Grice, J.E., and Parker, M.J. 2008. Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury. 39:1157-1163.
4. Lyles, K.W., et al. 2007. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl. J. Med. 357:1799-1809.
5. Canalis, E., Giustina, A., and Bilezikian, J.P. 2007. Mechanisms of anabolic therapies for osteoporosis. N. Engl. J. Med. 357:905-916.
6. Krishnan, V., Bryant, H.U., and Macdougald, O.A. 2006. Regulation of bone mass by Wnt signaling. J. Clin. Invest. 116:1202-1209.
7. Macsai, C.E., Foster, B.K., and Xian, C.J. 2008. Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair. J. Cell. Physiol. 215:578-587.
8. Kuhl, M., and Pandur, P. 2008. Dorsal axis duplication as a functional readout for Wnt activity. Methods Mol. Biol. 469:467-476.
9. Hurlstone, A.F., et al. 2003. The Wnt/beta-catenin pathway regulates cardiac valve formation. Nature. 425:633-637.
10. Korinek, V., et al. 1998. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19:379-383.
11. Logan, C.Y., and Nusse, R. 2004. The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20:781-810.
12. Nusse, R., et al. 1991. A new nomenclature for int-1 and related genes: the Wnt gene family. Cell. 64:231.
13. Sharma, R.P., and Chopra, V.L. 1976. Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev. Biol. 48:461-465.
14. Nusse, R., and Varmus, H.E. 1982. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell. 31:99-109.
15. Brown, A.M., Papkoff, J., Fung, Y.K., Shackleford, G.M., and Varmus, H.E. 1987. Identification of protein products encoded by the proto-oncogene int-1. Mol. Cell. Biol. 7:3971-3977.
16. Brown, A.M., Wildin, R.S., Prendergast, T.J., and Varmus, H.E. 1986. A retrovirus vector expressing the putative mammary oncogene int-1 causes partial transformation of a mammary epithelial cell line. Cell. 46:1001-1009.
17. Kansara, M., et al. 2009. Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice. J. Clin. Invest. 119:837-851.
18. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M., and Issa, J.-P. 1998. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res. 72:141-196.
19. Suzuki, H., et al. 2004. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat. Genet. 36:417-422.
20. Herman, J.G., et al. 1995. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 55:4525-4530.
21. Liggett, W.H., Jr., and Sidransky, D. 1998. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16:1197-1206.
22. van de Wetering, M., et al. 2002. The beta-catenin/ TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:241-250.
23. Adams, P.D., and Enders, G.H. 2008. Wnt signaling and senescence: A tug of war in early neoplasia? Cancer Biol. Ther. 7:1706-1711.
24. Gnant, M., et al. 2009. Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer. N. Engl. J. Med. 360:679-691.